STIM1 Gene Myopathy Tubular Aggregate Type 1 Genetic Test
Cost: 3200.0 AED
Test Details:
STIM1 gene myopathy, tubular aggregate, type 1 is a rare genetic disorder characterized by muscle weakness and wasting. It is caused by mutations in the STIM1 gene, which provides instructions for producing a protein involved in calcium regulation in muscle cells.
Components:
- Price: 3200.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information:
Clinical History of Patient who is going for STIM1 Gene Myopathy, tubular aggregate, type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with STIM1 Gene Myopathy, tubular aggregate, type 1.
Test Process:
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. It allows for the identification of specific genetic mutations or variations associated with a particular disorder, such as STIM1 gene myopathy. NGS genetic testing for STIM1 gene myopathy, tubular aggregate, type 1 involves obtaining a DNA sample, usually through a blood sample or cheek swab. The DNA is then sequenced using NGS technology to identify any mutations or variations in the STIM1 gene.
Benefits and Implications:
The results of the NGS genetic test can help confirm a diagnosis of STIM1 gene myopathy and guide treatment decisions. It can also provide valuable information for genetic counseling and family planning. It is important to consult with a healthcare professional or genetic counselor to determine if NGS genetic testing is appropriate for individuals suspected of having STIM1 gene myopathy, tubular aggregate, type 1. They can provide further information on the test, its benefits, limitations, and potential implications.
Test Name | STIM1 Gene Myopathy tubular aggregate type 1 Genetic Test |
---|---|
Components | |
Price | 3200.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for STIM1 Gene Myopathy, tubular aggregate, type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with STIM1 Gene Myopathy, tubular aggregate, type 1 |
Test Details |
STIM1 gene myopathy, tubular aggregate, type 1 is a rare genetic disorder characterized by muscle weakness and wasting. It is caused by mutations in the STIM1 gene, which provides instructions for producing a protein involved in calcium regulation in muscle cells. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. It allows for the identification of specific genetic mutations or variations associated with a particular disorder, such as STIM1 gene myopathy. NGS genetic testing for STIM1 gene myopathy, tubular aggregate, type 1 involves obtaining a DNA sample, usually through a blood sample or cheek swab. The DNA is then sequenced using NGS technology to identify any mutations or variations in the STIM1 gene. The results of the NGS genetic test can help confirm a diagnosis of STIM1 gene myopathy and guide treatment decisions. It can also provide valuable information for genetic counseling and family planning. It is important to consult with a healthcare professional or genetic counselor to determine if NGS genetic testing is appropriate for individuals suspected of having STIM1 gene myopathy, tubular aggregate, type 1. They can provide further information on the test, its benefits, limitations, and potential implications. |